Evidence map›Paper›PMID 34568709›Full record

ArticleJournal of the Endocrine Society2021

Genome-wide Association Study of Lipid Traits in Youth With Type 2 Diabetes.

Nicola Santoro, Ling Chen, Jennifer Todd, Jasmin Divers, Amy S Shah, Samuel S Gidding, Brian Burke, Morey Haymond, Leslie Lange, Santica Marcovina and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the Endocrine Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 13 institutions in 2 countries.

Nicola SantoroDivision of Pediatric Endocrinology, Yale School of Medicine, New Haven, CT, USA.ORCID https://orcid.org/0000-0001-6437-4173
Ling ChenCenter for Genomic Medicine and Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA.
Jennifer ToddDivision of Pediatric Endocrinology, University of Vermont, Burlington, VT, USA.
Jasmin DiversDivision of Health Services Research, NYU Long Island School of Medicine, Mineola, NY, USA.
Amy S ShahCincinnati Children's Hospital Medical Center & The University of Cincinnati, Cincinnati, OH, USA.
Samuel S GiddingGeisinger, Danville, PA.
Brian BurkeThe George Washington University, Washington, DC, USA.
Morey HaymondDivision of Pediatric Endocrinology, Baylor College of Medicine, Houston, TX, USA.
Leslie LangeDepartment of Medicine, University of Colorado, Denver, CO, USA.
Santica MarcovinaDepartment of Medicine, University of Washington, Seattle, WA, USA.
Jason FlannickDepartment of Pediatrics, Boston Children's Hospital, Boston, MA, USA.
Sonia CaprioDivision of Pediatric Endocrinology, Yale School of Medicine, New Haven, CT, USA.ORCID https://orcid.org/0000-0002-7523-5053
Jose C FlorezCenter for Genomic Medicine and Diabetes Unit, Massachusetts General Hospital, Boston, MA, USA.
Shylaja SrinivasanDivision of Pediatric Endocrinology, University of California at San Francisco, San Francisco, CA, USA.ORCID https://orcid.org/0000-0002-8049-6370
Broad Institute · USBaylor College of Medicine · USCincinnati Children's Hospital Medical Center · USGeisinger Medical Center · USGeorge Washington University · USLong Island University · USMassachusetts General Hospital · USUniversity of California, San Francisco · USUniversity of Colorado Denver · USUniversity of Molise · ITUniversity of Vermont · USUniversity of Washington · USYale University · US

Funding

Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) StudyU01DK061230 · NIDDK · GEORGE WASHINGTON UNIVERSITY · PI BRAFFETT, BARBARA HALINA, ZEITLER, PHILIP S. · 2001 to 2019
$231.8M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Institute of Translational Health SciencesUL1TR000423 · NCATS · UNIVERSITY OF WASHINGTON · PI DISIS, MARY L. · 2012 to 2016
$49.4M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI GERALD I SHULMAN · 1993 to 2026
$44.0M
LCenter for Clinical and Translational Science and TrainingUL1TR001425 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., KISSELA, BRETT M · 2015 to 2024
$37.5M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
UCSF Nutrition Obesity Research CenterP30DK098722 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CHRISTIAN VAISSE · 2015 to 2026
$14.6M
UCHSC DIABETES ENDOCRINOLOGY RESEARCH CENTERP30DK057516 · NIDDK · UNIVERSITY OF COLORADO DENVER · PI HUTTON, JOHN C · 2000 to 2010
$14.0M
Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E. · 2012 to 2014
$9.9M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
Training Program in Pediatric EndocrinologyT32DK007161 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Brian J Feldman, STEPHEN E GITELMAN · 1986 to 2026
$6.2M
Limited Competition for the Closeout of the SEARCH for Diabetes in Youth Cohort StudyR01DK127208 · NIDDK · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI DAGOSTINO, RALPH B., JENSEN, ELIZABETH T · 2020 to 2020
$2.0M
NCATS NIH HHS UL1 TR000062NCATS NIH HHS UL1 TR000077NCATS NIH HHS UL1 TR000154NCATS NIH HHS UL1 TR000423NCATS NIH HHS UL1 TR001425NCATS NIH HHS UL1 TR001863NHLBI NIH HHS K24 HL157960NIDDK NIH HHS K23 DK120932NIDDK NIH HHS P30 DK045735NIDDK NIH HHS P30 DK057516NIDDK NIH HHS P30 DK098722NIDDK NIH HHS R01 DK127208NIDDK NIH HHS T32 DK007161NIDDK NIH HHS U01 DK061230
6 · The paper itself

Abstract

contextDyslipidemia is highly prevalent in youth with type 2 diabetes (T2D), yet the pathogenic components of dyslipidemia in youth with T2D are poorly understood.

objectiveTo evaluate the genetic determinants of lipid traits in youth with T2D through a genome-wide association study. DESIGN PARTICIPANTS AND

main outcome measuresWe genotyped 206 928 variants and imputed 17 642 824 variants in 1076 youth (mean age 15.0 ± 2.48 years) with T2D from the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) and SEARCH for Diabetes in Youth (SEARCH) studies as part of the Progress in Diabetes Genetics in Youth (ProDiGY) consortium. We performed association testing for triglyceride and low-density lipoprotein cholesterol and high-density lipoprotein cholesterol (HDL-c) concentrations adjusted for the genetic relationship matrix within each substudy followed by meta-analyses for each trait.

resultsWe identified a novel association between a deletion on chromosome 3 (3:67817380_AT/A_Deletion:RP11-81N13.1) and triglyceride levels at genome-wide level of significance (

conclusionsOur genetic analyses of lipid traits in youth with T2D have identified 1 novel and 1 previously known locus. Additional studies are needed to further characterize the genetic architecture of dyslipidemia in youth with T2D.

Indexed as

dyslipidemiageneticsHDL-cLDL-ctriglyceridestype 2 diabetesyouth

Identifiers

PMID34568709
PMCPMC8459445
OpenAlexW3194233165

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.